Jacobs Levy Equity Management’s Bio-Techne TECH Stock Holding History

Jacobs Levy Equity Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-126,800	Closed	-$2.93M	–	874
2015 Q3	$2.93M	Hold	126,800	–	–	0.06%	289
2015 Q2	$3.12M	Sell	126,800 -17,560	-12%	-$438K	0.06%	297
2015 Q1	$3.62M	Buy	144,360 +105,000	+267%	+$2.5M	0.06%	276
2014 Q4	$909K	Buy	+39,360	New	+$901K	0.02%	523

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Jacobs Levy Equity Management's TECH Position: Q4 2015 in Review

Jacobs Levy Equity Management sold out of Bio-Techne (TECH) in Q4 2015, closing a stake of 126,800 shares — an estimated $2.93M sold.

Jacobs Levy Equity Management first reported a position in TECH in Q4 2014 and held it in 4 quarters. The position peaked at $3.62M in Q1 2015. 260 funds tracked by Wall St. Rank hold TECH as of Q4 2015.

Jacobs Levy Equity Management reported no remaining Bio-Techne position as of Q4 2015 after selling out during the quarter.
Jacobs Levy Equity Management sold 126,800 Bio-Techne shares in Q4 2015, an estimated $2.93M.
Jacobs Levy Equity Management first reported a position in Bio-Techne in Q4 2014 and held it in 4 quarters.
Jacobs Levy Equity Management's Bio-Techne position peaked at $3.62M in Q1 2015.
260 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2015.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2015, filed 16 Feb 2016.